SCHEMBL3792191

SCHEMBL3792191

CCCNc1ccccc1B(O)O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.49
LIPG Q9Y5X9 1/20 0.43
MAPT P10636 2/20 0.42
HTT P42858 2/20 0.42
MAPK1 P28482 1/20 0.37
KDM6B O15054 1/20 0.37
KDM4C Q9H3R0 1/20 0.37
ENPP2 Q13822 1/20 0.36
PDE5A O76074 1/20 0.36
EPHX1 P07099 1/20 0.36
KDM4E B2RXH2 1/20 0.35
GLA P06280 1/20 0.35
PGR P06401 1/20 0.35
SCN1A P35498 1/20 0.35
SCN2A Q99250 1/20 0.35
SCN3A Q9NY46 1/20 0.35
KMT2A Q03164 1/20 0.34
LIPE Q05469 1/20 0.34
LMNA P02545 2/20 0.34
L3MBTL1 Q9Y468 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3186346 0.84 KDM4E (0.50) MAPTHTTMAPK1ENPP2KDM4E
SCHEMBL3786294 0.83 IDO1 (0.46) IDO1LIPGMAPTHTTENPP2
SCHEMBL29953234 0.83 IDO1 (0.46) IDO1LIPGMAPTHTTENPP2
SCHEMBL11512622 0.80 IDO1 (0.55) IDO1MAPTHTTMAPK1KDM6B
SCHEMBL20296892 0.78 ENPP2 (0.38) IDO1LIPGMAPTHTTENPP2
SCHEMBL1955931 0.75 IDO1 (0.61) IDO1MAPTHTTMAPK1KDM4E
SCHEMBL28732241 0.75 IDO1 (0.52) IDO1MAPTHTTMAPK1KDM6B
SCHEMBL2493412 0.73 IDO1 (0.50) IDO1MAPTHTTMAPK1KDM6B
SCHEMBL5823951 0.73 KMT2A (0.40) MAPTHTTKDM4EKMT2ALMNA
SCHEMBL13477752 0.72 IDO1 (0.48) IDO1MAPTHTTMAPK1KDM6B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2010-04-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND NISCH, BLVRB, BBOX1 IDO1 310/4885LIPG 3010/4885MAPT 3312/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.